Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
4.360
+0.130 (3.07%)
Apr 1, 2025, 4:00 PM EDT - Market closed
CPIX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 36.54 | 37.51 | 40.68 | 35.05 | 35.84 | Upgrade
|
| Other Revenue | 1.33 | 2.04 | 1.33 | 0.94 | 1.6 | Upgrade
|
| Revenue | 37.87 | 39.55 | 42.01 | 35.99 | 37.44 | Upgrade
|
| Revenue Growth (YoY) | -4.26% | -5.85% | 16.75% | -3.89% | 8.88% | Upgrade
|
| Cost of Revenue | 6.59 | 6.07 | 9.12 | 8.81 | 8.65 | Upgrade
|
| Gross Profit | 31.28 | 33.49 | 32.89 | 27.17 | 28.79 | Upgrade
|
| Selling, General & Admin | 28.15 | 29.1 | 26.84 | 24.8 | 24.96 | Upgrade
|
| Research & Development | 4.82 | 5.83 | 6.69 | 5.68 | 5.77 | Upgrade
|
| Operating Expenses | 37.71 | 39.7 | 38.6 | 34.85 | 35.17 | Upgrade
|
| Operating Income | -6.43 | -6.21 | -5.7 | -7.68 | -6.38 | Upgrade
|
| Interest Expense | -0.61 | -0.67 | -0.59 | -0.1 | -0.26 | Upgrade
|
| Interest & Investment Income | 0.33 | 0.29 | 0.1 | 0.03 | 0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 3.3 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -6.7 | -3.29 | -6.19 | -7.75 | -6.57 | Upgrade
|
| Asset Writedown | - | -3.34 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 2.19 | - | Upgrade
|
| Pretax Income | -6.47 | -6.28 | -5.58 | -5.56 | -6.57 | Upgrade
|
| Income Tax Expense | -0.02 | 0.05 | 0.07 | 0.03 | 0.06 | Upgrade
|
| Earnings From Continuing Operations | -6.44 | -6.33 | -5.65 | -5.6 | -6.63 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 1.99 | 3.21 | Upgrade
|
| Net Income to Company | -6.44 | -6.33 | -5.65 | -3.6 | -3.42 | Upgrade
|
| Minority Interest in Earnings | -0.04 | 0.05 | 0.08 | 0.1 | 0.08 | Upgrade
|
| Net Income | -6.48 | -6.28 | -5.57 | -3.51 | -3.34 | Upgrade
|
| Net Income to Common | -6.48 | -6.28 | -5.57 | -3.51 | -3.34 | Upgrade
|
| Shares Outstanding (Basic) | 14 | 14 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 14 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | -1.67% | -1.82% | -2.29% | -1.70% | -1.52% | Upgrade
|
| EPS (Basic) | -0.46 | -0.44 | -0.38 | -0.24 | -0.22 | Upgrade
|
| EPS (Diluted) | -0.46 | -0.44 | -0.38 | -0.24 | -0.22 | Upgrade
|
| Free Cash Flow | -0.68 | 5.81 | 8.35 | 6.24 | 5.27 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | 0.41 | 0.57 | 0.42 | 0.35 | Upgrade
|
| Gross Margin | 82.61% | 84.66% | 78.30% | 75.51% | 76.89% | Upgrade
|
| Operating Margin | -16.99% | -15.70% | -13.58% | -21.34% | -17.04% | Upgrade
|
| Profit Margin | -17.11% | -15.88% | -13.26% | -9.75% | -8.92% | Upgrade
|
| Free Cash Flow Margin | -1.79% | 14.70% | 19.88% | 17.34% | 14.09% | Upgrade
|
| EBITDA | -1.53 | -1.27 | -0.38 | -3.07 | -1.63 | Upgrade
|
| EBITDA Margin | -4.04% | -3.22% | -0.90% | -8.53% | -4.36% | Upgrade
|
| D&A For EBITDA | 4.9 | 4.94 | 5.33 | 4.61 | 4.75 | Upgrade
|
| EBIT | -6.43 | -6.21 | -5.7 | -7.68 | -6.38 | Upgrade
|
| EBIT Margin | -16.99% | -15.70% | -13.58% | -21.34% | -17.04% | Upgrade
|
| Revenue as Reported | 37.87 | 39.55 | 42.01 | 35.99 | 37.44 | Upgrade
|
| Advertising Expenses | 2.99 | 2.9 | 2.93 | 1.93 | 2.38 | Upgrade
|
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.